Tamas Gonda is a Gastroenterology physician affiliated with NYU Langone Health. OpenAlex indexes 340 publications with 5,149 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
Sponsor: NYU Langone Health
- EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.5%Antidiarrheal microorganisms35%Creon100%Part D<11 patientsProton pump inhibitor27.5%Omeprazole100%Part D<11 patientsAnti-infectives
37.5%Cephalosporin Antibacterial37.5%Cefpodoxime Proxetil100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2014–2023 per NIH RePORTER. The latest:
- Predictive Biosignature for Endoscopic Therapy for Chronic Pancreatitis Pain
New York University School of Medicine
FY2023$1,244,812UG3NS135170 - Targeting the Microenvironment in Gastric Chemoprevention
Columbia University Health Sciences
FY2018$167,724K08DK100544 - Targeting the Microenvironment in Gastric Chemoprevention
Columbia University Health Sciences
FY2017$167,724K08DK100544
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Large-scale multi-center CT and MRI segmentation of pancreas with deep learning
Medical Image Analysis
2024 - Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma
Clinical Gastroenterology and Hepatology
2023 - Benefit of Extended Surveillance of Low-Risk Pancreatic Cysts After 5-Year Stability: A Systematic Review and Meta-Analysis
Clinical Gastroenterology and Hepatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”